These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Glycosaminoglycan sulfation determines the biochemical properties of prion protein aggregates. Ellett LJ; Coleman BM; Shambrook MC; Johanssen VA; Collins SJ; Masters CL; Hill AF; Lawson VA Glycobiology; 2015 Jul; 25(7):745-55. PubMed ID: 25701659 [TBL] [Abstract][Full Text] [Related]
4. Copaxone interferes with the PrP Sc-GAG interaction. Engelstein R; Ovadia H; Gabizon R Eur J Neurol; 2007 Aug; 14(8):877-84. PubMed ID: 17662008 [TBL] [Abstract][Full Text] [Related]
5. The metabolism of glycosaminoglycans is impaired in prion diseases. Mayer-Sonnenfeld T; Zeigler M; Halimi M; Dayan Y; Herzog C; Lasmezas CI; Gabizon R Neurobiol Dis; 2005 Dec; 20(3):738-43. PubMed ID: 15951190 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein. Kim DH; Lee HM; Ryou C J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058 [TBL] [Abstract][Full Text] [Related]
7. Variation in Chst8 gene expression level affects PrPC to PrPSc conversion efficiency in prion-infected Mov cells. Martin R; Chantepie S; Chapuis J; Le-Duc A; Maftah A; Papy-Garcia D; Laude H; Petit JM; Gallet PF Biochem Biophys Res Commun; 2011 Oct; 414(3):587-91. PubMed ID: 21982770 [TBL] [Abstract][Full Text] [Related]
8. The Size and Stability of Infectious Prion Aggregates Fluctuate Dynamically during Cellular Uptake and Disaggregation. Shoup D; Priola SA Biochemistry; 2021 Feb; 60(5):398-411. PubMed ID: 33497187 [TBL] [Abstract][Full Text] [Related]
9. PrPSc incorporation to cells requires endogenous glycosaminoglycan expression. Hijazi N; Kariv-Inbal Z; Gasset M; Gabizon R J Biol Chem; 2005 Apr; 280(17):17057-61. PubMed ID: 15668233 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of PrPSc formation by synthetic O-sulfated glycopyranosides and their polymers. Yamaguchi S; Nishida Y; Sasaki K; Kambara M; Kim CL; Ishiguro N; Nagatsuka T; Uzawa H; Horiuchi M Biochem Biophys Res Commun; 2006 Oct; 349(2):485-91. PubMed ID: 16949037 [TBL] [Abstract][Full Text] [Related]
12. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion. Silva JL; Vieira TC; Gomes MP; Rangel LP; Scapin SM; Cordeiro Y Methods; 2011 Mar; 53(3):306-17. PubMed ID: 21145399 [TBL] [Abstract][Full Text] [Related]
13. Host Determinants of Prion Strain Diversity Independent of Prion Protein Genotype. Crowell J; Hughson A; Caughey B; Bessen RA J Virol; 2015 Oct; 89(20):10427-41. PubMed ID: 26246570 [TBL] [Abstract][Full Text] [Related]
14. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein. Biochem Biophys Res Commun; ; . PubMed ID: 15582583 [TBL] [Abstract][Full Text] [Related]